- Resource
- BR1DGE
- Monitoring
- Staging
- Video
The BR1DGE Podcast - Episode 1: How Should We Monitor People with I-Ab Positivity
Partha Kar talks to Sanjoy Dutta, CSO of Breakthrough T1D, about how to monitor people with IAb positivity.
Learning Objectives
- Learn about the mission of Breakthrough T1D from its Chief Scientific Officer
- Explore how to monitor people with IAb positivity and how the Breakthrough T1D Consensus Guidance can support clinicians with this in daily practice
Summary
The BR1DGE Podcast features Dr. Sanjoy Dutta of Breakthrough T1D (formerly JDRF), discussing the exciting advancements in T1D research. He details how detection of individuals with pre-clinical T1D through autoantibody status enables implementation of intervention strategies to forestall disease progression. The conversation emphasizes the new Consensus Guidance for monitoring individuals with autoantibody positivity. This guidance aims to standardize care, prevent dangerous diabetic ketoacidosis, and promote the incorporation of crucial psychosocial support. The discussion underscores the need for a multidisciplinary approach to T1D management, offering hope for improved outcomes and a “softer landing” when clinical T1D ultimately develops.
MAT-GLB-2500703-1.0 - 04/2025
The Importance of Early T1D Detection
Learn about autoimmune type 1 diabetes (T1D) and the importance of early detection through islet autoantibody (IAb) screening.
.png/jcr:content/400x300_Early%20Identification%20The%20Role%20of%20C-peptide%20in%20the%20Diagnosisand%20Management%20of%20T1D%20(1).png)
Early Identification: The Role of C-peptide in the Diagnosis and Management of T1D
Expert interview highlighting the importance and role of C-peptide during the diagnosis and management of type 1 diabetes
Clear Communication is Essential to Convey the Benefits of T1D Screening
Clear communication about risks, disease stages, and early detection is a key component of successful T1D screening (Prof. Michael Haller).